Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy

Tara Anne Collidge1, Peter Campbell Thomson, Patrick Barry Mark

  • 1Renal Unit and Radiology Department, Glasgow Royal Infirmary, Castle Street, 3rd Floor Walton Bldg, Glasgow G4 0SF, Scotland.

Radiology
|August 21, 2007
PubMed

Insights

Gadolinium-based contrast agents are associated with nephrogenic systemic fibrosis in dialysis patients. Higher cumulative doses and more frequent administration increased the risk of developing this condition.

Area of Science:

  • Nephrology
  • Radiology
  • Toxicology

Background:

  • Nephrogenic systemic fibrosis (NSF) is a debilitating condition linked to gadolinium-based contrast agents (GBCAs).
  • Dialysis-dependent patients with established renal failure are particularly vulnerable to NSF.
  • Understanding the relationship between GBCA exposure and NSF is crucial for patient safety.

Purpose of the Study:

  • To compare GBCA administration frequency and cumulative dose in dialysis patients who developed NSF versus those who did not.
  • To investigate the association between GBCA exposure parameters and NSF development.

Main Methods:

  • Retrospective analysis of adult dialysis patients in West Scotland (2000-2006).
  • Recorded diagnoses of NSF, GBCA-enhanced MRI episodes, and cumulative GBCA doses.
  • Analyzed outcomes using parametric and nonparametric statistical tests.

Main Results:

  • 14 out of 1826 patients developed NSF.
  • Patients with NSF were significantly more likely to have undergone GBCA-enhanced MRI (93% vs 22.5%, P<.001).
  • NSF patients received higher median cumulative doses of gadodiamide (0.39 vs 0.23 mmol/kg, P=.008) and more GBCA-enhanced MR imaging sessions.

Conclusions:

  • GBCA administration is positively associated with NSF development in patients with renal failure.
  • Higher cumulative doses of gadodiamide and increased dosing events correlate with increased NSF risk.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...